InMed Pharmaceuticals, Inc. (INM)
0.6401
-0.01
(-1.54%)
USD |
NASDAQ |
May 15, 16:00
0.65
+0.01
(+1.55%)
After-Hours: 20:00
InMed Pharmaceuticals Free Cash Flow : -7.710M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CannaPharmaRx, Inc. | -0.7891M |
| Lexaria Bioscience Corp. | -9.470M |
| Target Group, Inc. (Canada) | -0.4808M |
| Tilray Brands, Inc. | -75.96M |
| NervGen Pharma Corp. | -17.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.759M |
| Cash from Financing (Quarterly) | 0.2315M |
| Free Cash Flow Per Share (Quarterly) | -0.4345 |
| Free Cash Flow to Equity (Quarterly) | -1.647M |
| Free Cash Flow to Firm (Quarterly) | -1.759M |
| Free Cash Flow Yield | -345.1% |